News (Page 2)

Parabolic Drugs Limited get approval from Ranbaxy for supply of regulated 6 APA for Ranbaxy’s US markets from PDL’s Panchkula facility, subsequent to PDL filing DMF for USFDA approval in 2005.

Ranbaxy has been informed by USFDA that they can now start sourcing 6 APA from Parabolic’s Panchkula facility for Ranbaxy’s US markets. This approval came subsequent to PDL filing a DMF for USFDA approval in 2005 for its Panchkula 6 APA facility. This places PDL in a strategic position in the Pencillins business and also…

→ Read more

Draft red herring prospectus filed on March 3rd, 2006

Parabolic Drugs Limited is planning to offer 25,00,000 shares to the public in its maiden public offer expected in April/May 2006. In this regard the company filed a draft prospectus with SEBI on February 27, 2006. The funds from the issue will be used to fund the expansion plans of PDL which include setting up…

→ Read more